A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
Recruiting · NCT07459634 · Registry updated 2026-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Phase 2 | 2026-09-17 | NCT07459634 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jazz Pharmaceuticals | 60 |
| Jazz Pharmaceuticals Ireland Limited | 7 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baptist Health | Lexington | United States | 7 |
| Cancer Specialists of North Florida | Jacksonville | United States | 24 |
| Carolina Blood and Cancer Care | Rock Hill | United States | 2 |
| Emory University | Atlanta | United States | 262 |
| Valkyrie Clinical Trials, Inc. | Los Angeles | United States | 1 |